Literature DB >> 23208041

[Development of an efficient short interference RNA (siRNA) delivery system with a new pH-sensitive cationic lipid].

Yusuke Sato1, Hiroto Hatakeyama, Mamoru Hyodo, Hidetaka Akita, Hideyoshi Harashima.   

Abstract

The development of a carrier for the delivery of siRNA is a factor in the realization of RNA interference (RNAi) therapeutics. Modification of siRNA carriers with polyethylene glycol, i.e., PEGylation, is a general strategy for stabilizing a particle in the blood stream and delivering it to tissue or cells. However, it is well-known that, when a carrier is modified by PEGylation, it results in a significant inhibition of both cellular uptake and the endosomal escape process. In a previous study, we reported on the development of a multifunctional envelope-type nano device (MEND) for delivering siRNA and peptide-based functional devices for overcoming the effects conferred by PEGylation and succeeded in the delivery of siRNA to tumor tissue. In this study, we noticed that the pH-sensitive property, changing from neutral to cationic in response to a decrease in pH, could avoid the inhibition caused by PEGylation and succeeded in synthesizing a pH-sensitive cationic lipid, YSK05. The YSK05-MEND had a higher fusogenicity and potency for endosomal escape than other MENDs containing conventional cationic lipids. The PEGylated YSK05-MEND induced efficient gene silencing and avoided the inhibition of endosomal escape caused by PEGylation followed by optimization of the lipid composition. Furthermore, the intratumoral injection of the PEGylated YSK05-MEND resulted in a more efficient gene silencing compared with MENDs containing conventional cationic lipids. Thus, the YSK05-MEND is a promising siRNA carrier for avoiding the inhibition in intracellular trafficking caused by PEGylation both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23208041     DOI: 10.1248/yakushi.12-00234-2

Source DB:  PubMed          Journal:  Yakugaku Zasshi        ISSN: 0031-6903            Impact factor:   0.302


  2 in total

1.  3B, a novel of photosensitizer, exhibited anti-tumor effects via mitochondrial apoptosis pathway in MCF-7 human breast carcinoma cells.

Authors:  Kecheng Lei; Shaoying Tan; Wenpei Du; Yichun Xu; Shengchao Lin; Yuanhong Zheng; Fangyuan Zou; Yufang Xu; Jianwen Liu
Journal:  Tumour Biol       Date:  2015-02-27

2.  Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting.

Authors:  Nour Shobaki; Yusuke Sato; Hideyoshi Harashima
Journal:  Int J Nanomedicine       Date:  2018-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.